Since CCR2 is highly expressed on joint infiltrated monocytes/macrophages in RA patients and CIA animals [13], targeted inhibition of CCR2 was initially thought to be a promising therapeutic strategy for the treatment of RA. Here, CCR2 is linked to rheumatoid arthritis.